RAC 1.11% $1.83 race oncology ltd

Ann: Supply Agreement for EMD AML Trial, page-13

  1. 498 Posts.
    lightbulb Created with Sketch. 613
    Wow, great out of left field announcement!

    • Drug provided free of charge by Otsuka...
    • First seen details about the upcoming trial design and locations. Those details seem to indicate trial design is progressing well. => Ethics approval soon?
    • It looks like the EM AML trial that was planned at Calvary Mater Newcastle hospital (old RACE strategy) has been officially forked into the new FTO trial, effectively recycling a previous agreement into the new FTO pillar (Am I reading this right?)

    While we're at it, we are still expecting final data on Nikki's preclinical on EM AML. While we received some interim data there should be an update on mouse studies. Also Nikki's work is expected to be published in a peer-reviewed journal at some point, which should be announced in due time.

    I also speculate RACE will have the companion diagnostic (CDx) ready before starting the trial. It would make sense to use the CDx in such trial.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.